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886 C. G. GROTH AND T. E. STARZL 
The first attempt at hepatic transplantation in man was made in 1963 
[11. In the ensuing 10 years, close to 70 patients were treated with such an 
operation at our institution. By now, a significant number of recipients 
have benefited from the procedure through return to an essentially normal 
life. Since 1972, better selection of reCipients, increased attention to sur-
gical details, and better methods of immunosuppression have improved the 
results to some extent. 
This chapter first describes the indications for hepatic transplantation. 
Second, the special :lurgical and immunologic problems of the procedure 
are outlined. Third, some intriguing metabolic consequences of hepatic 
replacement are described. Finally, the long-term results are presented. 
I. SELECTION OF RECIPIENTS 
All patients with end-stage liver disease for which no other form of 
treatnlent is available should be considered as possible candidates for 
hepatic transplantation. Howeve"r, --patients with severe extrahepatic disease 
or psychiatric abnormalities, including uncontrolled alcoholism, should 
usually be excluded. On-going infections constitute a potential contraindica-
tion because of the necessity to compromise the patients immunologic 
response after transplantation. Finally, patients over 45 years of age should 
presently not be considered for transplantation; of eight attempts at 
treatment in this age group in Denver, all have failed in the first few post-
operative months. 
Nonresectible, malignant liver tumor was initially believed to be an 
important indication for liver replacement and our experience at Denver 
included patients afflicted with hepatoma, cholangiocarcinoma, and hemangio-
endothialsarcoma, but none with secondary hepatic tumor. Before proceed-
". ing with transplantation in these cases, great care was exercised to exclude 
the existence of extrahepatiC metastases. Nonetheless, tumor spread was 
subsequently encountered in a prohibitive number of cases. 
Noncorrectable, congenital extrahepatic biliary atresia presently con-
stitutes the most definite indication for liver transplantation because of its 
inexorable course. In the case of intrahepatic biliary atresia, the indication 
is more relative because prolonged survival is achieved in some instances 
with conservative treatment. 
For children with intrahepatic atresia, as well as for adult patients with 
liver failure caused by other kinds of nonneoplastic disease, the decision 
for transplantation must be based on a highly individualized evaluation of the 
patient's prognosis. When the first attempts were made to treat patients in 
liver failure caused by nonneoplastic hepatic disease, it was necessary to 
wait until there was clearly no hope. Consequently, gastrointestinal bleeding, 
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26. TRANSPLA NTA TION OF THE LIVER 887 
hepatic coma, or renal insufficiency were usually present. Obviously, such 
conditions reduced the chances for success. With recent improvements in 
results, there should be justification to operate before the advent of these 
terminal complications. 
In Denver, biliary atresia has been the most common single indication 
for hepatic transplantation. Most of the chilch'en have been between 1 and'-
2 years of age, but the youngest has been treated at 3 months of age. More 
recently, the number of patients with chronic aggressive hepatitis and 
cirrhosis has increased. The latter group includes patients with Laennec's 
cirrhosis, primary biliary cirrhosis, and juvenile cirrhosis. In addition, 
two boys with Wilson's hepaticolenticular degeneration have been treated 
with hepatic replacement. 
ll. SURGICAL CONSIDERATIONS 
A. The Graft 
Hepatic homografts can obViously be obtained from cadaveric donors 
only. The requirements for a physiologically satisfactory donor include 
the absence of malignancy or generalized sepsis and a reasonable size 
similarity to that of the reCipient. In the early days of Jlver transplantation, 
most patients received grafts that had been damaged by ischemia while 
residing in the donor. Since the acceptance in 1968 of the brain death criteria, 
it has been possible to harvest the liver before circulatory arrest or if 
necessary, the cadaver can be supported by a heart-lung machine. At extir-
pation, the liver is cooled and cleared of blood by brief perfuSion with a 
chilled electrolyte solution. After removal, the viability at the graft may 
be preserved for sever'al hours by continuous hypothermic perfusion in 
vitro [2]. -
B. The Transplantation 
Two different procedures are available [2]. In orthotopic liver trans-
plantation, the diseased, native liver is removed and replaced by a graft 
with anatomic reconstruction of the vasculature (Fig. 1). In this operation, 
the removal of the native liver may be a most difficult undertaking because 
of extensive adhesions around the liver, portal hypertension, and scarring 
caused by previous surgical interventions. The implantation of the graft 
entails end-to-end anastomosis of the inferior vena cava above and below 
the liver and of the portal vein. In two instances existing portacaval shunts 
) 
1 ' 
1 
} 
) 
i 
.. 
1 
, :1 
; II 
... 
" 
888 C. G. GROTH AND T. E. STARZL 
have had to be taken down. In patients with standard hepatic arterial 
anatomy, reconstruction is with an end-to-end anastomosis. However, in 
several instances it has been necessary to accommodate vascular anomalies 
in the graft or recipient (Fig. 1). A biliary outflow tract is usually accom-
plished by cholecystoduodenostomy, following ligation of the graft and 
patient common bile duct. Choledochoduodenostomyor end-to-end anasto-
mosis of the graft and recipient common ducts have also been employed. 
The last procedure obviously cannot be applied in cases with biliary atresia. 
A. 
FIG. 1. Orthotopic liver transplantation. (A) Anatomic reconstruction 
of the inferior vena cava (I. V .C.), above and below the liver, and of the 
portal vein (p. V.) and the hepatic artery (H.A.). Biliary drainage is with 
cholecystoduodenostomyafter ligation of the graft as well as the patient's 
common duct. (B) and (C) Arterial reconstruction used in two patients in 
whom the homograft had a double arterial blood supply. (B) Two anasto-
moses; (C) anastomosis of donor to recipient aorta. Several other vari-
ations have been necessary in other patients. [By permission of Ann. Surg., 
168, 392 (1968). I 
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26. TRANSPLANTATION OF THE LIVER 889 
The alternative procedure, which can be used in nonmalignant hepatic 
disease, is the insertion of a heterotopic hepatic graft with the diseased 
native liver left in place (Fig. 2). In this operation the inflow into the graft 
portal vein may be from the patient's systemic venous system (vena cava 
or iliac vein), or from splanchnic sources following anastomosis of the graft 
portal vein to the recipient splenic or mesenteric vein. If systemic blood 
is used for portal inflow, a standard shunt procedure may have to be added 
in order to relieve existing portal hypertension. Cholecystoenterostomy 
provides a biliary outflow tract. 
C. Postoperative Care 
Prior to 1968 several patients received grafts badly damaged by ischemia. 
In these cases, there was invariably an abnormal bleeding tendency during 
the operation and the postoperative course was complicated by clotting 
abnormalities, hypoglycemia, and the !ieveloPr:nent of a third fluid space with 
hypoproteinemia. There was also severe 'electrolyte and acid-base dis-
turbances. 
In contrast, the early course after the provision of a well-functioning 
graft is usually not difficult. Elaborate respiratory care with frequent 
monitoring of arterial blood gases may be important. Repe.ated measure-
ments of serum potassium and glucose with swift and appropriate adjustments 
in therapy are also important. Albumin and diuretics are usually adminis-
tered over the first several postoperative days. Vitamin K is given to 
support the synthesis of prothrombin. In most patients antibiotics covering 
a broad spectrum of gram-negative and -positive bactelia are administered 
for the first postoperative week. 
D. Technical Complications 
Although portal or caval vascular complications have been uncommon, 
a 5-10% incidence of graft hepatiC arterial thrombosis has occurred. If the 
occlusion is complete, graft necrosis and patient death ensue. The small 
size of the vessels, especially in children and in patients with arterial 
vascular anomalies, is probably the main cause of this complication but the 
multiple effects of the liver on blood coagulation with the evolution of a 
hypercoagulable state may be contributing factors. 
So far, cholecystoduodenostomy has been the most common choice for 
biliary tr act reconstruction. It has become clear, however, that this kind 
of anastomosis is accompanied by a 20% or greater frequency of obstruction 
at the site of the cystic duct, caused either by surgical errors or most 
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STAGE n. 
Roux-Y loop over 
left lobe 
axis 
FIG. 2. Heterotopic liver transplantation. (A) The incision; (B) 
portacaval shunt performed prior to transplantation; (C) the hepatic graft 
revascularized in the lower abdomen. The portal inflow is from the patient's 
inferior vena cava; the inferior end of the graft vena cava has been closed. 
The hepatic artery of the graft is anastomosed to the recipient aorta. Biliary 
drainage is with cholecystoenterostomy to a Roux-Y loop. In other patients 
the portal vein has been anastomosed to the splenic or mesenteric vein, 
thereby providing inflow of splanchnic blood into the graft. Abbreviations as 
in Fig. 1. [By permission of Arch. &Irg., 93, 107 (1966).] 
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26. TRANSPLANTATION OF THE LIVER 891 
commonly, by swelling or secondary distortion of the duct wall. It has been 
shown that infestation of duct epithelium with such agents as cytomegalovirus 
may lead to delayed bile stasis. 
Whatever the cause, with obstruction a characteristic syndrome develops 
with rises in serum bilirubin and alkaline phosphatase and with fever and 
gram-negative septicemia in the event of cholangitis [3] (Fig. 3). Secondary,-
reconstructions have been carried out with one of the other methods men-
tioned above, but with a few exceptions the patients have succumbed from 
intrahepatic abscesses or cholangitis. The use of primary choledochoduo-
denostomy or choledochocholedochostomy averts this dangerous complication 
but these methods have been reported to carry a higher risk of bile leakage 
[2, 4]. 
Unusual surgical complications include venous infarction of the right 
adrenal gland secondary to caval resection, paralysis of the right hemidia-
phragm caused by inadvertent crushing of the right phrenic nerve with 
vascular clamps, and intraoperative air embolism. 
III. IMMUNOLOGIC CONSIDERATIONS 
A. Graft Rejection 
Until 1970, an attempt was made to select a donor-recipient combination 
on the basis of antigenic Similarity as measured with histocompatibility 
(HL-A) testing. With the finding in the last few years that the degree of 
such Similarity did not correlate well with clinical results in rLcipients of 
nonrelated homografts, the interest in this kind of "immunologic" selection 
diminished. 
When acute homograft rejection occurs there is fever and an increase 
in liver size. The most characteristic changes in the standard liver function 
tests include an increase in serum bilirubin and alkaline phosphatase that 
parallels concomitant morphologic findings of intrahepatic cholestasis. If 
the condition progresses, rises in the serum transaminases, prolongation 
of prothrombin time, and other indications of cellular injury occur (Fig. 4). 
Standard biochemical tests thus differentiate poorly between graft 
rejection and other forms of hepatic pathology, i.e., biliary obstruction, 
infectious hepatitis, and injury caused by drugs, all of which may occur in 
homograft recipients. Intravenous or percutaneous transhepatic cholangio-
grams, technetium and Rose Bengal radioisotope scans, needle biopsy, and 
the determination in serum of Australia antigen can all aid in the differential 
diagnosis. 
BLOOD CULTURE 
TEMPERATURE 
(OC) 
PLATELET COUNT 
(x I03/mm3) 
PROTHROMBIN 
TIME (%) 
SGOT-
(I U) 
SGPT ----
(I U) • 
ALKALINE''! 
PHOSPHATASE 
(W) 
BILIRUBIN 
(mg/IOO ml) 
TOTAL -
CONJUGATED ----
HYDROCORTI SONE 
500 mg 
PREDNISONE 
(mg/doy) 
CYCLOPHOS PHAMIDE 
(mg/doy) 
HORSE ALG 
HEPATIC 
TRANSPLANTATION 
AFTER 
CHOL £ DOCHO-
DUODENOS TOMY 
FIG. 3. The course of a 16-year-old recipient of a hepatic homograft. 
Although liver function was satisfactory initially, hyperbilirubinemia 
developed 15 days after operation but receded slightly with intensification 
of immunosuppression. SystemiC sepsis prompted reexploration, at which 
time a cholangiogram showed an obstructed duct system. Biliary diversion 
was converted to choledochoduodenostomy. However, the child died of 
uncontrolled sepsis 46 days after transplantation. [By permission of Surgery, 
72, 604 (1972). ] 
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26. TRANSPLA NTA TION OF THE LIVER 893 
Inadequate control of homograft rejection has been a major cause of 
failure in approximately one third of our patients. In a few patients with 
graft failure, a second transplantation has been carried out and in one case 
the recipient of a second graft has lived on for more than a year (Fig. 4). 
B. Immunosuppression 
The extensive experience with clinical renal transplantation provides the 
foundation for the immunosuppressive regimens used in human hepatic 
transplantation. The first patients have been given two immunosuppressive 
agents, the cytotoxic drug azathioprine and the synthetic adrenal corticoster-
oid prednisone. During the last several years heterologous antihuman 
lymphocyte globulin (ALG) has been added to this combination [2] (Fig. 4). 
More recently, another cytotoxic agent, cyclophosphamide, has been found 
to be as effective an immunosuppressant as azathioprine in man [5] and, 
because the former drug may be less hepatotoxic as well as less influenced 
by variations in liver function, it has been,used in the early postoperative 
period to'replace azathioprine [6J (Fig. 5). During the first postoperative 
weeks, prednisone is given in very high doses but subsequently the doses 
are gradually reduced (FIgs. 4 and 5). If evidence of graft rejection occurs 
the steroid dose is again increased. In most cases, the required nose of 
prednisone diminishes considerably with time. The mechanism underlying 
this "graft accommodation" is poorly understood but it is t~ prerequisite 
for long-term success because the side effects of prolonged administration 
of high doses of prednisone are prohibitive. 
The question concerning the effect of the liver on the metabolism of the 
immunosuppressive drugs has special implications in hepatic transplant 
reCipients. Cyclophosphamide becomes an active, immunosuppressive agent 
only after an in vivo activation process in which the liver plays an important 
role, and the same consideration probably applies to azathioprine. Con-
sequently, the drugs may become less activated and thus decreasingly 
immunosuppressive if the liver function deteriorates. Alternatively, because 
the degradation and detoxification of azathioprine, cyclophosphamide, and 
prednisone occur mainly in the liver, it may be suggested that the effect of 
the drugs becomes enhanced with liver dysfunction. In fact, some evidence 
has been adduced that renal transplant recipients require reduced immuno-
suppression when they are afflicted with severe liver dysfunction. However, 
the practical implications of the described interactions between the immuno-
suppressive drugs and the liver for the care of the hepatic transplant recipient 
remain obscure. 
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C. The Compromised Host 
The dose of immunosuppression required to prevent rejection may 
induce various degrees of immunologic invalidism. As a consequence, a 
large number of patients have had a postoperative course complicated by 
severe pulmonary or systemic infections. Often, the infectious agent has 
belonged to the opportunistic organisms that become pathogenic only in an 
immunologically compromised host. Examples are Candida, Aspergillus, 
Nocardia, and Cryptococcus among the fungi; cytomegalovirus, herpes 
simplex, and varicella-zoster among the viruses; and a nonclassified 
microorganism, Pneumocystitis carinii (Fig. 6). Infections with all these 
organisms have been encountered in hepatic transplant recipients and in 
many patients such infections have contributed to early or late postoperative 
death. 
In addition to these infections, which plague an patients on immuno-
suppression, the liver recipients have had a high incidence of septicemia 
with gram-negative bacteria of the types existing in the endogenous intestinal 
flora. Evidence indicates that the hepatic graft, during biliary obstruction 
or when afflicted by rejection, readily becomes infected with such bacteria, 
which then enter the systemic circulation. In some patients large septic 
infarcts have developed, probably as a consequence of uncontrolled rejection 
(Fig. 7). Frequebt blood cultures are important in caring for these recipi-
ents and growth of gram-negative bacteria in the bloodstream is strong 
evidence of graft injury or obstruction. 
IV. SPECIAL METABOLIC CONSIDERATIONS 
- ~ 
A. Plasma Proteins 
In early experimental and clinical studies it was not unexpectedly 
reported that most of the electrophoretic ally measurable protein fractions 
declined rapidly after the implantation of a poorly functioning hepatic homo-
graft [2). In contrast, these fractions were well maintained after provision 
of a properly functioning graft. A similar relationship between the quality 
of graft function and protein levels was found also for the liver based clotting 
factors. The changes in these latter factors were very rapid and reflected 
"'changes in consumption as well as in synthesis [2]. 
More recently, the complement system was assayed in recipients of 
hepatic homo grafts [7]. In five patients with terminal liver failure, suc-
cessful replacement of the diseased livers restored markedly depressed total 
complement activity as well as the C4 and C3 component activities. At the 
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ZL 26. TRANSPLANTATION OF THE LIVER 901 
same time the Cs component increased from low to high normal. In contrast, 
the C2 and Cg components were normal throughout, whereas C1 showed 
variable changes (Fig. 8). 
Two of the recipients developed postoperative liver function abnormal- -
ities that were thought to be caused by homograft rejection. Concomitantly 
there were marked decreases in total complement activity and in the C4 and 
C3 components (Fig. 8). One of these patients later developed biliary 
obstruction that required surgical correction. At this time there were no 
changes in the complement system. Two other patients had temporary liver 
dysfunction at a time when steep rises in Australia antigen titers indicated 
the occurrence of serum hepatitis. In one of these patients, a transient 
decrease in complement activities was recorded but in the other the com-
plement remained unaffected. 
It is concluded from these data that complement assays may aid in the 
otherwise equivocal diagnosis of hepatic homograft rejection. In addition, 
the data are consistent with the hypothesis ~hat the liver is a main or possibly 
even the sole source of the C4 , C3 , and Cs components of the complement 
system. 
B. Inborn Errors of Metabolism 
'I' 
In several liver transplant recipients, the genetically determined pheno-
types of the a-globulins, haptoglobin, and group-specific component con-
verted to those of the donors [21. This early finding indicated that the 
hepatic homograft retained its metabolic specificity in a new host and that 
the liver-based inborn errors of metabolism would be correctable by the 
provision of anew, normal "liver • 
There have not yet been any successful liver transplantations for a proved 
inborn error of hepatic metabolism. However, two Denver patients under-
went liver replacement for Wilson's disease, a disorder that has been 
speculated to be caused by a hepatic defect. The first patient, who was 
transplanted when in terminal liver failure, had a marked cupruresis follow-
ing transplantation, and biopsy specimens of the graft collected over 3 years 
have shown no accumulation of copper as had occurred in the native liver. 
The second patient had all the classical stigmata of Wilson's disease, 
with a very low level of the copper-containing serum protein ceruloplasmin, 
a low total serum copper, a high urinary copper excretion, and a high Liver 
copperj postnecrotic cirrhosis and Kayser-Fleischer rings were found as 
well. In spite of treatment wito chelating agents, the patient became severely 
crippled by neurologic symptoms. When hepatic transplantation was carried 
out it was hoped that the provision of a normal liver would improve the 
copper metabolism with consequent amelioration of the extrahepatic mani-
festations of the disease [81. 
HEPATIC 
TRANSPLANTATION 
CH50 
(unitsnnl) 
IA50 
(reciprocal 
of liter) 
CI 
C4 
C2 
C3 
C9 
(unitslml) 
CIq 
(,,",,/mD 
C4 
(mgImO 
~K 
(1119/m1) 
C5 
(mQ/mll 
SGOT (LU) 
SGPT (LU) 
BILlRlBIN 
(mg/lOOmI) 
qlqAi~lqbfk 
ALBUMIN 
r GLOBULIN 
AZATHIOPRINE 
(mQlday) 
PREDNISONE 
(mQ/day) 
ALG 
o 10 20 30 40 50 60 
TIME IN DAYS 
FIG. 8. Changes in the complement system in a patient who developed 
liver dysfunction 3 weeks after operation presumably because of rejection. 
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26. TRANSPLANTATION OF THE LIVER 903 
Several findings indicated that the handling of copper was indeed affected. 
The serum ceruloplasmin and copper normalized shortly after transplantation 
and biopsy specimens of the graft showed only a slightly elevated copper 
concentration (Fig. 5). Moreover, the neurologic symptoms abated and 
the Kayser-Fleischer rings became less prominent, indicating that the 
extrahepatic manifestations were being favorably affected by the hepatic 
replacement. These findings were consistent with the hypothesis that the 
metabolic defect in Wilson's disease was liver based. The future course 
could provide grounds for a definite conclusion concerning the role of the 
liver in the pathogenesis of the disease. 
V. LATE RESULTS 
In Denver, 62 patients have been treated with orthotopic liver trans-
plantation up until the end of 1972. Fifteen have survived the first post-
operative year and three have lived past 3 years. Eleven patients are 
presently alive, the two longest survivors having essentially normal hepatic 
function 3 years, 10 months and 3 years, 4 months after the operation, 
respectively (Table 1). 
Following transplantation for benign liver disease, tJtree of seven 
patients afflicted with chronic aggressive hepatitis survived for at least 1 
year. Promising results have been recorded also in the treatment of 
Wilson's disease; two patients are alive more than 2 and 3 years after 
surgery. Among the children with biliary atresia the i-year survival rate 
is six of 27; two of the patients that survived beyond 3 years were in this 
group (Table 1). 
The worst results in the Denver series have been in patients suffering 
from Laennec's or primary biliary cirrhosis, with only two of 13 patients 
surviving beyond 1 year. The reason for this is probably an unfavorable 
case selection and should not discourage further efforts to operate on such 
patients (Table 1). 
Of a total of six patients with the primary diagnosis of malignant hepatic 
tumor (five hepatomas, one sarcoma) who lived more than 2 months after 
transplantation, all eventually died with tumor recurrence. Two of the 
patie~ lived beyond 1 year posttransplantation. In these two cases, and 
Legend for Fig. 8 cont. 
Note the concomitant marked drop in total complement and several of the 
components. Subsequently, biliary tract obstruction was diagnosed without 
the occurrence of changes in complement. The patient succumbed 16 days 
later; shortly before death complement levels again decreased. [By 
permission of Clin. Exp. Immunol., 12, 21 (1972). J 
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906 C. G. GROTH AND T. E. STARZL 
TABLE 1 
Denver Series of Orthotopic Hepatic Transplantation 
Survivors (years) 
Indications Total number 1 2 
Biliary atresiaa 27 6b 3 2 
Cirrhosis 13 2 
Chronic aggressive 7 3 
hepatitis 
Wilson's disease 2 2 2 1 
Carcinoma 12 2 
Sarcoma 1 
Total 62 15 
Presently alive 
aOne patient had a small hepatoma. 
b . 
One patient received two grafts. 
J: 
in two of the others L the metastases had also invaded the graft (Fig. 9). The 
only patient at risk in whom metastases did not develop was a child treated 
more than 3 years ago for biliary atresia. In this case a small hepatoma 
was an incidental finding. Survival for several years after liver replace-
ment without recurrence of malignancy was also reported by Daloze in 
Montreal and Caine in Cambridge, England. 
The rapidity and extent of occurrence of posttransplantation metastases 
in the patients treated for hepatic malignancies may be related to the immuno-
suppressive treatment. Loss of the "immunologic surveillance" by which 
mutant cells can be eliminated or restricted in their growth potential has 
been postulated in the immunologically compromised patients [9]. 
There has been no example of extended survival among a total of four 
patients treated with heterotopic hepatic transplantation at our center. A 11 
recipients died in the first postoperative months from complications directly 
related to the grafting or from progressive hepatic insufficiency not relieved 
by the transplantation. Inherent disadvantages of the method probably account 
for the poor results. These include technical difficulties with the nonanatom-
ical anastomoses, and abdominal overcrowding caused by the addition of an 
extra organ. In addition, residual function in a host liver may enable it, 
by a process loosely termed "interliver competition," to depreciate the 
chances of good function and survival of the transplant. These disadvantages 
apparently offset the possible advantage offered by retaining the residual 
function of the native liver. 
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26. TRANSPLANTATION OF THE LIVER 907 
Considerably better results than in the total series have been achieved 
in cases treated with orthotopic transplantation during 1972. Seven out of 
11 patients (64%) are presently alive with a followup time ranging from 6 
to 18 months. These results indicate that the prospects for success are 
now approaching those for cadaveric renal transplantation. 
Several reasons for the improvements are obvious. First, the operation .. ~ 
has been performed at an earlier stage, i. e. , before the patient is agonal, 
as has so often been the case in the past. Second, extensive collaboration 
within the medical community regarding utilization of organs from patients 
with brain death have increased the chances of treating more patients at 
the right time. Third, careful preoperative evaluation of vascular and 
biliary anatomy primarily with radiographic techniques has prevented some 
of the technical complications. Fourth, patients with hepatic malignancy 
have been excluded from consideration for the time being. Fifth, aggressive 
reexploration and secondary reconstruction of biliary continuity has been 
practiced in the last year, with euccessful conversion of cholecystoduodeno-
stomy in two cases. Finally, some improvements in the means for control-
ling of the immune response have been a~ievedK 
The improved results warrant a conSiderably larger number of cases 
to be treated with hepatic transplantation in the future. The vast need for 
this kind of radical treatment in hepatic disease can be appreciated from 
the other chapter of this book. 
1. 
2. 
3. 
4. 
5. 
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